Tidal Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.35M Sell
14,265
-126
-0.9% -$56.1K 0.04% 389
2025
Q1
$6.98M Sell
14,391
-3,962
-22% -$1.92M 0.06% 324
2024
Q4
$7.39M Buy
18,353
+6,672
+57% +$2.69M 0.06% 318
2024
Q3
$5.43M Sell
11,681
-303
-3% -$141K 0.06% 303
2024
Q2
$5.62M Sell
11,984
-3,098
-21% -$1.45M 0.08% 233
2024
Q1
$6.3M Buy
15,082
+4,036
+37% +$1.69M 0.1% 182
2023
Q4
$4.49M Sell
11,046
-623
-5% -$253K 0.1% 161
2023
Q3
$4.06M Sell
11,669
-3,260
-22% -$1.13M 0.12% 158
2023
Q2
$5.25M Sell
14,929
-2,335
-14% -$822K 0.15% 115
2023
Q1
$5.44M Sell
17,264
-6,867
-28% -$2.16M 0.18% 109
2022
Q4
$6.97M Sell
24,131
-898
-4% -$259K 0.27% 69
2022
Q3
$7.25M Buy
25,029
+8,281
+49% +$2.4M 0.3% 54
2022
Q2
$4.72M Sell
16,748
-1,762
-10% -$496K 0.17% 103
2022
Q1
$4.83M Buy
+18,510
New +$4.83M 0.14% 117
2021
Q4
Sell
-8,410
Closed -$1.53M 1062
2021
Q3
$1.53M Buy
8,410
+2,248
+36% +$408K 0.06% 219
2021
Q2
$1.24M Buy
6,162
+3,337
+118% +$673K 0.05% 240
2021
Q1
$607K Buy
2,825
+770
+37% +$165K 0.03% 262
2020
Q4
$486K Buy
2,055
+607
+42% +$144K 0.03% 235
2020
Q3
$394K Buy
1,448
+160
+12% +$43.5K 0.05% 174
2020
Q2
$374K Sell
1,288
-509
-28% -$148K 0.05% 186
2020
Q1
$428K Buy
1,797
+492
+38% +$117K 0.13% 130
2019
Q4
$286K Sell
1,305
-410
-24% -$89.9K 0.12% 149
2019
Q3
$291K Buy
+1,715
New +$291K 0.13% 133